Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1979 1
1982 1
1983 1
1984 2
1985 1
1987 1
1988 5
1989 6
1990 6
1991 2
1992 2
1993 7
1994 7
1995 12
1996 8
1997 13
1998 13
1999 9
2000 19
2001 27
2002 24
2003 24
2004 25
2005 48
2006 57
2007 38
2008 64
2009 89
2010 75
2011 99
2012 93
2013 97
2014 112
2015 128
2016 144
2017 162
2018 132
2019 163
2020 205
2021 286
2022 319
2023 312
2024 111

Text availability

Article attribute

Article type

Publication date

Search Results

2,740 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Did you mean jun fu (667 results)?
Constraint-induced movement therapy for upper extremities in people with stroke.
Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Corbetta D, et al. Cochrane Database Syst Rev. 2015 Oct 8;2015(10):CD004433. doi: 10.1002/14651858.CD004433.pub3. Cochrane Database Syst Rev. 2015. PMID: 26446577 Free PMC article. Review.
OBJECTIVES: To assess the efficacy of CIMT, modified CIMT (mCIMT), or forced use (FU) for arm management in people with hemiparesis after stroke. SEARCH METHODS: We searched the Cochrane Stroke Group trials register (last searched June 2015), the Cochrane Central Re …
OBJECTIVES: To assess the efficacy of CIMT, modified CIMT (mCIMT), or forced use (FU) for arm management in people with hemiparesis a …
Chemotherapy for advanced gastric cancer.
Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S. Wagner AD, et al. Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4. Cochrane Database Syst Rev. 2017. PMID: 28850174 Free PMC article. Review.
Additionally, oxaliplatin-containing regimens demonstrated a benefit in OS as compared to the same regimen containing cisplatin, and there is a modest survival improvement of S-1 compared to 5-FU-containing regimens.Whether the survival benefit for three-drug combinations …
Additionally, oxaliplatin-containing regimens demonstrated a benefit in OS as compared to the same regimen containing cisplatin, and there i …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122 Suppl 1:S59. doi: 10.1002/jcb.30027. Epub 2021 Jun 30. J Cell Biochem. 2021. PMID: 34191298
Retraction: "The Role of MicroRNA-143-5p in the Differentiation of Dental Pulp Stem Cells into Odontoblasts by Targeting Runx2 via the OPG/RANKL Signaling Pathway," by Fu-Liang Zhan, Xin-Yang Liu, Xing-Bo Wang, J Cell Biochem. 2018; 536-546: The above article, published on …
Retraction: "The Role of MicroRNA-143-5p in the Differentiation of Dental Pulp Stem Cells into Odontoblasts by Targeting Runx2 via the OPG/R …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122 Suppl 1:S109. doi: 10.1002/jcb.30089. Epub 2021 Jul 19. J Cell Biochem. 2021. PMID: 34288061
Retraction: "TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer," by Yuan Tian, Lian-Lian Liu, Dong-Mei Guo, Yan Wang, Wen-Hui Zha, Yang Li, Fu-Ju Wu, J Cell Biochem. 2018; 7540-7555 …
Retraction: "TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in …
Clinical concept extraction: A methodology review.
Fu S, Chen D, He H, Liu S, Moon S, Peterson KJ, Shen F, Wang L, Wang Y, Wen A, Zhao Y, Sohn S, Liu H. Fu S, et al. J Biomed Inform. 2020 Sep;109:103526. doi: 10.1016/j.jbi.2020.103526. Epub 2020 Aug 6. J Biomed Inform. 2020. PMID: 32768446 Free PMC article. Review.
METHODS: Based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a literature search was conducted for retrieving EHR-based information extraction articles written in English and published from January 2009 through June 2019 fro …
METHODS: Based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a literature search was conduc …
Insulin-like growth factor-1 and retinopathy of prematurity: A systemic review and meta-analysis.
Fu Y, Lei C, Qibo R, Huang X, Chen Y, Wang M, Zhang M. Fu Y, et al. Surv Ophthalmol. 2023 Nov-Dec;68(6):1153-1165. doi: 10.1016/j.survophthal.2023.06.010. Epub 2023 Jul 7. Surv Ophthalmol. 2023. PMID: 37423521 Review.
We searched for PubMed, Web of Science, Embase, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, SinoMed, ClinicalTrials.gov, and 3 Chinese databases up to June 2022. Then, the meta-regression and subgroup analysis were carried out. ...
We searched for PubMed, Web of Science, Embase, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, SinoMed, ClinicalTrials.go …
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.
Dolat M, Macaire P, Goirand F, Vincent J, Hennequin A, Palmier R, Bengrine-Lefevre L, Ghiringhelli F, Royer B, Schmitt A. Dolat M, et al. Pharmaceuticals (Basel). 2020 Nov 23;13(11):416. doi: 10.3390/ph13110416. Pharmaceuticals (Basel). 2020. PMID: 33238487 Free PMC article.
All patients with gastrointestinal cancers who received 5-FU-based regimens form March 2018 to June 2020 were included in our study. They routinely benefited of a pre-therapeutic DPYD genotyping and phenotyping. During 5-FU infusion, blood samples were collec …
All patients with gastrointestinal cancers who received 5-FU-based regimens form March 2018 to June 2020 were included in our …
Comparing the Efficacy of Multiple Drugs Injection for the Treatment of Hypertrophic Scars and Keloid: A Network Meta-Analysis.
Wu W, Zhao Y, Chen Y, Zhong A. Wu W, et al. Aesthetic Plast Surg. 2023 Feb;47(1):465-472. doi: 10.1007/s00266-022-03163-4. Epub 2022 Dec 19. Aesthetic Plast Surg. 2023. PMID: 36536095 Free PMC article. Review.
METHODS: Relevant literature was extracted from the following databases Cochrane Library, Embase, PubMed, Web of Science, CNKI, Weipu, and Wanfang until June 2022, such as randomized clinical trials (RCTs) evaluating different injected drugs for the treatment of pathologic …
METHODS: Relevant literature was extracted from the following databases Cochrane Library, Embase, PubMed, Web of Science, CNKI, Weipu, and W …
Heterologous expression of bacterial natural product biosynthetic pathways.
Huo L, Hug JJ, Fu C, Bian X, Zhang Y, Müller R. Huo L, et al. Nat Prod Rep. 2019 Oct 16;36(10):1412-1436. doi: 10.1039/c8np00091c. Nat Prod Rep. 2019. PMID: 30620035 Review.
Covering: 2013 to June 2018 Heterologous expression of natural product biosynthetic pathways is of increasing interest in microbial biotechnology, drug discovery and optimization. ...
Covering: 2013 to June 2018 Heterologous expression of natural product biosynthetic pathways is of increasing interest in microbial b …
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer.
Takada R, Ikezawa K, Yamai T, Watsuji K, Seiki Y, Kawamoto Y, Hirao T, Higashi S, Urabe M, Kai Y, Nakabori T, Uehara H, Kotani M, Yagi T, Kimura M, Nozaki K, Takagi M, Ohkawa K. Takada R, et al. BMC Cancer. 2023 Jul 31;23(1):711. doi: 10.1186/s12885-023-11205-6. BMC Cancer. 2023. PMID: 37518012 Free PMC article.
BACKGROUND: Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU)/levo-leucovorin (Levo-LV) was approved for unresectable pancreatic cancer (UR-PC) in March 2020 in Japan. ...METHODS: We retrospectively reviewed the data of 69 patients with UR-PC who received nal-I …
BACKGROUND: Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU)/levo-leucovorin (Levo-LV) was approved for unresectable pan …
2,740 results